Latest Insider Transactions at Hologic Inc (HOLX)
This section provides a real-time view of insider transactions for Hologic Inc (HOLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HOLOGIC INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HOLOGIC INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2022
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+8.13%
|
-
|
|
Feb 24
2022
|
Sean S. Daugherty Group President, BSH & Surg. |
SELL
Open market or private sale
|
Direct |
2,179
-4.25%
|
$154,709
$71.14 P/Share
|
|
Nov 19
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,570
-14.14%
|
$192,750
$75.79 P/Share
|
|
Nov 12
2021
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
2,027
-2.79%
|
$147,971
$73.54 P/Share
|
|
Nov 12
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-1.59%
|
$21,389
$73.54 P/Share
|
|
Nov 12
2021
|
Sean S. Daugherty Group President, BSH & Surg. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,406
-11.11%
|
$467,638
$73.54 P/Share
|
|
Nov 12
2021
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,184
-7.72%
|
$962,432
$73.54 P/Share
|
|
Nov 12
2021
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-3.29%
|
$20,586
$73.54 P/Share
|
|
Nov 12
2021
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
6,833
-10.21%
|
$498,809
$73.54 P/Share
|
|
Nov 12
2021
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
91,777
-3.75%
|
$6,699,721
$73.54 P/Share
|
|
Nov 11
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-1.71%
|
$23,184
$72.61 P/Share
|
|
Nov 11
2021
|
Sean S. Daugherty Group President, BSH & Surg. |
SELL
Payment of exercise price or tax liability
|
Direct |
556
-0.95%
|
$40,032
$72.61 P/Share
|
|
Nov 11
2021
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,297
-0.75%
|
$93,384
$72.61 P/Share
|
|
Nov 11
2021
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-3.22%
|
$20,520
$72.61 P/Share
|
|
Nov 11
2021
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
632
-0.94%
|
$45,504
$72.61 P/Share
|
|
Nov 11
2021
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-0.85%
|
$65,664
$72.61 P/Share
|
|
Nov 11
2021
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,345
-0.3%
|
$528,840
$72.61 P/Share
|
|
Nov 09
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-1.13%
|
$15,265
$71.26 P/Share
|
|
Nov 09
2021
|
Sean S. Daugherty Group President, BSH & Surg. |
SELL
Payment of exercise price or tax liability
|
Direct |
469
-0.8%
|
$33,299
$71.26 P/Share
|
|
Nov 09
2021
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-2.14%
|
$13,774
$71.26 P/Share
|
|
Nov 09
2021
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
590
-0.87%
|
$41,890
$71.26 P/Share
|
|
Nov 09
2021
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-0.42%
|
$22,010
$71.26 P/Share
|
|
Nov 09
2021
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.63%
|
$48,280
$71.26 P/Share
|
|
Nov 09
2021
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,173
-0.17%
|
$296,283
$71.26 P/Share
|
|
Nov 08
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+9.98%
|
-
|
|
Nov 08
2021
|
Sean S. Daugherty Group President, BSH & Surg. |
BUY
Grant, award, or other acquisition
|
Direct |
5,272
+8.24%
|
-
|
|
Nov 08
2021
|
Elisabeth A Hellmann SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+18.89%
|
-
|
|
Nov 08
2021
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
6,150
+8.28%
|
-
|
|
Nov 08
2021
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
5,272
+6.73%
|
-
|
|
Nov 08
2021
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+6.14%
|
-
|
|
Nov 08
2021
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
35,146
+1.41%
|
-
|
|
Nov 01
2021
|
Sean S. Daugherty Group President, BSH & Surg. |
BUY
Grant, award, or other acquisition
|
Direct |
26,816
+33.42%
|
-
|
|
Nov 01
2021
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
43,252
+20.59%
|
-
|
|
Nov 01
2021
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
28,764
+31.7%
|
-
|
|
Nov 01
2021
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
23,087
+25.41%
|
-
|
|
Nov 01
2021
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,424
+30.17%
|
-
|
|
Nov 01
2021
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
240,732
+9.03%
|
-
|
|
Aug 10
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-22.84%
|
$385,000
$77.48 P/Share
|
|
Aug 10
2021
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+18.59%
|
$185,000
$37.64 P/Share
|
|
Aug 09
2021
|
John M. Griffin General Counsel |
SELL
Open market or private sale
|
Direct |
26,683
-17.76%
|
$2,001,225
$75.62 P/Share
|
|
Aug 09
2021
|
John M. Griffin General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
26,683
+15.08%
|
$987,271
$37.64 P/Share
|
|
Jul 01
2021
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-0.78%
|
$23,517
$67.99 P/Share
|
|
May 10
2021
|
Sean S. Daugherty Group President, BSH & Surg. |
SELL
Open market or private sale
|
Direct |
4,001
-13.07%
|
$260,065
$65.02 P/Share
|
|
Mar 11
2021
|
Sally Crawford Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+1.14%
|
-
|
|
Mar 11
2021
|
Scott T Garrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+2.26%
|
-
|
|
Mar 11
2021
|
Ludwig Hantson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+18.55%
|
-
|
|
Mar 11
2021
|
Namal Nawana Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+8.87%
|
-
|
|
Mar 11
2021
|
Christiana Stamoulis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+3.49%
|
-
|
|
Mar 11
2021
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+8.39%
|
-
|
|
Mar 11
2021
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,478
+28.57%
|
-
|